/주식/VTGN
VTGN

VTGN

USD

Vistagen Therapeutics Inc. Common Stock

$4.070-0.110 (-2.632%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$4.180

고가

$4.296

저가

$4.060

거래량

0.21M

기업 기본 정보

시가총액

124.9M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.57M

거래소

NCM

통화

USD

52주 범위

저가 $1.9현재가 $4.070고가 $4.65

관련 뉴스

BusinessWire

Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called

더 보기
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
BusinessWire

Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder

Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a

더 보기
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder